The Cigna Group
CI
$271.63
-$9.64-3.43%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.13B | 69.52B | 66.94B | 65.26B | 65.37B |
| Total Other Revenue | 339.00M | 233.00M | 236.00M | 238.00M | 277.00M |
| Total Revenue | 72.47B | 69.75B | 67.18B | 65.50B | 65.65B |
| Cost of Revenue | 66.06B | 63.37B | 61.02B | 58.90B | 59.19B |
| Gross Profit | 6.42B | 6.38B | 6.16B | 6.61B | 6.46B |
| SG&A Expenses | 3.40B | 3.15B | 3.27B | 3.80B | 3.77B |
| Depreciation & Amortization | 463.00M | 436.00M | 422.00M | 422.00M | 424.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.91B | 66.96B | 64.71B | 63.12B | 63.38B |
| Operating Income | 2.56B | 2.79B | 2.47B | 2.39B | 2.27B |
| Income Before Tax | 1.82B | 2.30B | 2.02B | 1.65B | 2.01B |
| Income Tax Expenses | 543.00M | 322.00M | 389.00M | 239.00M | 473.00M |
| Earnings from Continuing Operations | 1.27B | 1.97B | 1.63B | 1.41B | 1.54B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -40.00M | -105.00M | -100.00M | -86.00M | -112.00M |
| Net Income | 1.23B | 1.87B | 1.53B | 1.32B | 1.42B |
| EBIT | 2.56B | 2.79B | 2.47B | 2.39B | 2.27B |
| EBITDA | 3.28B | 3.49B | 3.15B | 3.06B | 2.92B |
| EPS Basic | 4.67 | 7.02 | 5.76 | 4.88 | 5.13 |
| Normalized Basic EPS | 5.05 | 5.35 | 4.63 | 4.35 | 3.89 |
| EPS Diluted | 4.65 | 6.98 | 5.71 | 4.85 | 5.12 |
| Normalized Diluted EPS | 5.02 | 5.31 | 4.59 | 4.32 | 3.89 |
| Average Basic Shares Outstanding | 264.07M | 265.91M | 266.18M | 270.87M | 277.78M |
| Average Diluted Shares Outstanding | 265.67M | 267.53M | 268.15M | 272.95M | 277.78M |
| Dividend Per Share | 1.51 | 1.51 | 1.51 | 1.51 | 1.40 |
| Payout Ratio | 32.09% | 21.52% | 26.17% | 31.14% | 26.97% |